Black women with a family history of breast cancer can benefit from genetic testing to see if they carry the BRCA1 or BRCA2 mutations associated with a higher risk for the disease, and get early treatment if they do, according to a new study. Researchers urged additional study on the genetics of breast cancer, saying that despite the cost and lack of coverage for such testing, early detection improves survival rates.

Related Summaries